ZELTIQ Aesthetics (ZLTQ) Shares are Up 8.38%

ZELTIQ Aesthetics (ZLTQ) : Traders are bullish on ZELTIQ Aesthetics (ZLTQ) as it has outperformed the S&P 500 by a wide margin of 12.28% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 7.81%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 8.38% in the last 1 week, and is up 10% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The stock has recorded a 20-day Moving Average of 6.53% and the 50-Day Moving Average is 14.43%.The 200 Day SMA reached 41.14% ZELTIQ Aesthetics, Inc. is up 46.31% in the last 3-month period. Year-to-Date the stock performance stands at 41.85%.


ZELTIQ Aesthetics (ZLTQ) : 7 Wall Street analysts covering ZELTIQ Aesthetics (ZLTQ) believe that the average level the stock could reach for the short term is $43.43. The maximum price target given is $48 and the minimum target for short term is around $38, hence the standard deviation is calculated at $4.47.

For the current week, the company shares have a recommendation consensus of Buy. ZELTIQ Aesthetics (NASDAQ:ZLTQ): The stock opened at $40.25 and touched an intraday high of $40.98 on Friday. During the day, the stock corrected to an intraday low of $40, however, the bulls stepped in and pushed the price higher to close in the green at $40.47 with a gain of 0.82% for the day. The total traded volume for the day was 1,217,772. The stock had closed at $40.47 in the previous trading session.

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.